Actemra’s, an Arthritis Drug, Shows Promise of Treating Coronavirus

Roche Holding AG is supplying its arthritis drug Actemra to doctors on the front lines fighting the new coronavirus, Alexander Hardy, Chief Executive of Roche’s Genentech business, said during The Wall Street Journal Health Forum on Tuesday. Although Actemra has not gone under clinical trials as of yet, it shows great promise.

• https://www.biospace.com/article/regeneron-and-sanofi-aim-a-rheumatoid-arthritis-drug-at-coronavirus/